Detalhe da pesquisa
1.
Prognostic impact of early-versus-late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT.
Eur J Haematol
; 106(5): 708-715, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33580608
2.
High Graft-versus-Host Disease-Free, Relapse/Rejection-Free Survival and Similar Outcome of Related and Unrelated Allogeneic Stem Cell Transplantation for Aplastic Anemia: A Nationwide Swedish Cohort Study.
Biol Blood Marrow Transplant
; 25(10): 1970-1974, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31173901
3.
Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation.
Clin Infect Dis
; 67(4): 564-572, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29481599
4.
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents.
Biol Blood Marrow Transplant
; 24(5): 930-936, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29339268
5.
Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.
Haematologica
; 103(3): 514-521, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217776
6.
Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia - A Swedish nationwide cohort study.
Eur J Haematol
; 100(6): 613-620, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29532518
7.
Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011.
Haematologica
; 102(10): 1683-1690, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28751565
8.
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
J Neurol Neurosurg Psychiatry
; 85(10): 1116-21, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24554104
9.
Allogeneic stem cell transplantation for acquired pure red cell aplasia.
Am J Hematol
; 94(11): E294-E296, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31396977
10.
Listeria monocytogenes Infections in Hematopoietic Cell Transplantation Recipients: Clinical Manifestations and Risk Factors. A Multinational Retrospective Case-Control Study from the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Transplant Cell Ther
; 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621480
11.
Allogeneic hematopoietic stem cell transplantation for adult HLH: a retrospective study by the chronic malignancies and inborn errors working parties of EBMT.
Bone Marrow Transplant
; 57(5): 817-823, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35332305
12.
IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study.
Clin Lymphoma Myeloma Leuk
; 21(10): 686-693, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34158265
13.
Central nervous system disorders after hematopoietic stem cell transplantation: a prospective study of the Infectious Diseases Working Party of EBMT.
J Neurol
; 267(2): 430-439, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31664549
14.
Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry.
Bone Marrow Transplant
; 54(11): 1764-1774, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30962502
15.
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse.
JAMA Oncol
; 4(9): 1245-1253, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30003233